A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer

Oral Pilocarpine for Post-Irradiation Xerostomia in Patients with Head and Neck Cancer

Jonas T. Johnson, Gerald A. Ferretti, W. James Nethery et al. · New England Journal of Medicine · 1993 · 483 citations · Full text

Medicine, Pharmacotherapy, Radiation Oncology +15

Clinical Criteria for the Diagnosis of Salivary Gland Hypofunction

M. Navazesh, Carol M. Christensen, Vernon J. Brightman · Journal of Dental Research · 1992 · 327 citations

Dentistry, Oral Health Sciences, Oral Health +16

Development of a Visual Analogue Scale questionnaire for subjective assessment of salivary dysfunction

Satishchandra Pai, Elisa M. Ghezzi, Jonathan A. Ship · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · 2001 · 206 citations

Dentistry, Diagnostic Sciences, Psychometrics +9

Matched case–control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: Initial report

Siavash Jabbari, Hyungjin Myra Kim, Mary Feng et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 180 citations

Medicine, Oncology, Radiation Oncology +10

Xerostomia and associated factors in a community‐dwelling adult population

Ronald J. Billings, Howard M. Proskin, Mark E. Moss · Community Dentistry And Oral Epidemiology · 1996 · 148 citations

Dentistry, Oral Health Sciences, Oral Epidemiology +16